208 results on '"Carter, Lukas M."'
Search Results
2. Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer
3. Depth resolved pencil beam radiography using AI -- a proof of principle study
4. Simultaneous quantitative imaging of two PET radiotracers via the detection of positron–electron annihilation and prompt gamma emissions
5. Dosimetry in Radiopharmaceutical Therapy
6. Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
7. Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.
8. MIRD Pamphlet No. 30: MIRDfit—A Tool for Fitting of Biodistribution Time–Activity Data for Internal Dosimetry.
9. Imaging Early-Stage Metastases Using an 18F-Labeled VEGFR-1-Specific Single Chain VEGF Mutant
10. Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer
11. MIRD Pamphlet No. 29: MIRDy90--A 90Y Research Microsphere Dosimetry Tool.
12. MIB Guides: Preclinical Radiopharmaceutical Dosimetry
13. 212Pb-Pretargeted Theranostics for Pancreatic Cancer
14. The risk index as a basis for risk/benefit analyses and protocol optimization in diagnostic nuclear imaging
15. Addendum to MIRD Pamphlet No. 28
16. pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery
17. Fluorescence labeling of a NaV1.7-targeted peptide for near-infrared nerve visualization
18. Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer.
19. Metal-based Radiotherapeutics
20. MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
21. MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals
22. Influence of Body Posture on Internal Organ Dosimetry: Radiocesium Exposure Modeling Using Novel Posture-dependent Mesh Computational Phantoms
23. 212Pb-Pretargeted Theranostics for Pancreatic Cancer.
24. Supplementary Data from iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy
25. Table S2 from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
26. Figure S2 from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
27. Data from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
28. Data from iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy
29. Supplementary Data from Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
30. NMR and HRMS from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
31. Supplementary Data from Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma
32. Supplementary Figure from Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
33. Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers
34. Multiplexed imaging for diagnosis and therapy
35. Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
36. Dosimetric Variability Across a Library of Computational Tumor Phantoms
37. Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy
38. Calibration of a system for measurements of diffusion coefficients of fission products in HTGR/VHTR core materials
39. Dosimetric Variability Across a Library of Computational Tumor Phantoms.
40. PET Imaging of Acidic Tumor Environment With 89Zr-labeled pHLIP Probes
41. Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
42. Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
43. Reply: Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19
44. Patient Size-Dependent Dosimetry Methodology Applied to 18F-FDG Using New ICRP Mesh Phantoms
45. Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications
46. Technical Note: Patient‐morphed mesh‐type phantoms to support personalized nuclear medicine dosimetry — a proof of concept study
47. PET Imaging of Acidic Tumor Environment With 89Zr-labeled pHLIP Probes.
48. Imaging Early-Stage Metastases Using an 18F-Labeled VEGFR-1-Specific Single Chain VEGF Mutant
49. CAR Chase: Where Do Engineered Cells Go in Humans?
50. Oncology-Inspired Treatment Options for COVID-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.